Hepatitis C and Liver Transplantation

Overview

Journal Hippokratia

Specialty General Medicine

Date 2009 Dec 17

PMID 20011084

Citations 17

Authors

G Tsoulfas

I Goulis

D Giakoustidis

E Akriviadis

P Agorastou

G Imvrios

V Papanikolaou

Affiliations

Soon will be listed here.

Abstract

Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in Europe, United States and Japan. Reinfection after liver transplantation is universal and chronic liver disease develops in at least 70% of patients at 3 years, with an accelerated course compared to the nontransplant setting. These facts underscore the need for a better understanding of hepatitis C infection and the various treatment modalities. This paper attempts a brief review of the scope of the disease, as well as the different treatment modalities, with special emphasis given to orthotopic liver transplantation.

Citing Articles

Integrated transcriptomics and histopathology approach identifies a subset of rejected donor livers with potential suitability for transplantation.

Srivastava A, Manchel A, Waters J, Ambelil M, Barnhart B, Hoek J BMC Genomics. 2024; 25(1):437.

PMID: 38698335 PMC: 11067109. DOI: 10.1186/s12864-024-10362-7.

Managing HBV and HCV Infection Pre- and Post-liver Transplant.

Kumar N, Choudhary N J Clin Exp Hepatol. 2023; 14(2):101287.

PMID: 38076445 PMC: 10709521. DOI: 10.1016/j.jceh.2023.09.008.

Barriers and Facilitators to Hepatitis C Virus (HCV) Treatment for Aboriginal and Torres Strait Islander Peoples in Rural South Australia: A Service Providers' Perspective.

Lim D, Phillips E, Bradley C, Ward J Int J Environ Res Public Health. 2023; 20(5).

PMID: 36901423 PMC: 10002019. DOI: 10.3390/ijerph20054415.

Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.

Busschots D, Kremer C, Bielen R, Koc O, Heyens L, Nevens F BMC Public Health. 2022; 22(1):2159.

PMID: 36419013 PMC: 9685883. DOI: 10.1186/s12889-022-14623-6.

Revolution in the diagnosis and management of hepatitis C virus infection in current era.

Hanif F, Majid Z, Hassan Luck N, Tasneem A, Laeeq S, Mubarak M World J Hepatol. 2022; 14(4):647-669.

PMID: 35646260 PMC: 9099099. DOI: 10.4254/wjh.v14.i4.647.

References

Everson G, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B . Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology. 2005; 42(2):255-62. DOI: 10.1002/hep.20793. View

Strader D, Wright T, Thomas D, Seeff L . Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004; 39(4):1147-71. DOI: 10.1002/hep.20119. View

Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayon M, San Juan F . Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?. Liver Transpl. 2003; 9(11):1152-8. DOI: 10.1053/jlts.2003.50240. View

De Clercq E . Emerging antiviral drugs. Expert Opin Emerg Drugs. 2008; 13(3):393-416. DOI: 10.1517/14728214.13.3.393. View

Burak K, Kremers W, Batts K, Wiesner R, Rosen C, Razonable R . Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl. 2002; 8(4):362-9. DOI: 10.1053/jlts.2002.32282. View

Brown R . Hepatitis C and liver transplantation. Nature. 2005; 436(7053):973-8. DOI: 10.1038/nature04083. View

Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M . Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902):359-62. DOI: 10.1126/science.2523562. View

Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams J, Ortiz J . Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation. 2004; 77(2):190-4. DOI: 10.1097/01.TP.0000100481.14514.BB. View

Forns X, Garcia-Retortillo M, Serrano T, Feliu A, Suarez F, Mata M . Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol. 2003; 39(3):389-96. DOI: 10.1016/s0168-8278(03)00310-6. View

10.

Szabo E, Lotz G, Paska C, Kiss A, Schaff Z . Viral hepatitis: new data on hepatitis C infection. Pathol Oncol Res. 2003; 9(4):215-21. DOI: 10.1007/BF02893380. View

11.

Dumortier J, Scoazec J, Chevallier P, Boillot O . Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol. 2004; 40(4):669-74. DOI: 10.1016/j.jhep.2003.12.015. View

12.

. Hepatitis C--global prevalence (update). Wkly Epidemiol Rec. 2000; 74(49):425-7. View

13.

Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J . Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 1998; 28(3):823-30. DOI: 10.1002/hep.510280333. View

14.

Triantos C, Samonakis D, Stigliano R, Thalheimer U, Patch D, Burroughs A . Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation. 2005; 79(3):261-8. DOI: 10.1097/01.tp.0000149696.76204.38. View

15.

Thorburn D, Roy K, Wilson K, Stell D, Cameron S, Wall W . Anonymous pilot study of hepatitis C virus prevalence in liver transplant surgeons. Liver Transpl. 2006; 12(7):1084-8. DOI: 10.1002/lt.20757. View

16.

Davis G, Albright J, Cook S, Rosenberg D . Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003; 9(4):331-8. DOI: 10.1053/jlts.2003.50073. View

17.

Boker K, DALLEY G, Bahr M, Maschek H, Tillmann H, Trautwein C . Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997; 25(1):203-10. DOI: 10.1002/hep.510250137. View

18.

Berenguer M . What determines the natural history of recurrent hepatitis C after liver transplantation?. J Hepatol. 2005; 42(4):448-56. DOI: 10.1016/j.jhep.2005.01.011. View

19.

Kayali Z, Buckwold V, Zimmerman B, Schmidt W . Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology. 2002; 36(4 Pt 1):978-85. DOI: 10.1053/jhep.2002.35620. View

20.

Gane E . The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl. 2003; 9(11):S28-34. DOI: 10.1053/jlts.2003.50248. View